Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The £120k is invoiced this financial year , no mention of from which parts of the business, we are only one month into the current financial year, which makes interesting reading to me ; almost half of last year's revenue already. The word contract was heavily used in the now deleted tweet.
It's important to remember that bleepa is still on trial at Pennine, much of what feedback do will be based on feedback from the trial, today's news could well have been a request from the Pennine Trust, if so Feedback are demonstrating a can do attitude. This is what trials are for. News soon from Pennine hopefully? Maybe why TB turned out on the other channel?
He obviously has faith in Balagi Ganashan so probably Texrad he wants. I personally see a future for Texrad with a few updates it's time could still come. Was probably a bit before it's time with many not willing to trust the tech .
I wonder why he feels he can add value to Texrad? I was unfortunately a victim of his big sell off. Not a fan ,but he does know how to stoke a share price. Maybe he sees something coming here? He will buy if the opportunity is there despite any grievance he may have.
Https://www.nhsconfedconference.org/conference-agenda Taking stock of messaging apps: using safe, secure and compliant clinical messaging to drive efficiencies, negate clinical risk and improve care delivery 17 Jun 2021 08:00 - 08:55 S - Specialist sessions 3 The European Commission’s Medical Device Directive states that any platform that ‘displays digital patient images for the purpose of diagnosis’ by clinicians should hold a CE mark as a regulated medical device. However, with the current prevalence of clinicians using mainstream messaging and clinical communication platforms without it, there is a considerable liability risk for both organisations and individual clinicians. Healthcare organisations also have an obligation under GDPR as data controllers, which means that communication apps that contain patient information should include a data processing agreement between the manufacturer and any organisation whose employees are using it. This applies to apps offered to clinicians under a ‘freemium’ model, even if the organisation itself has not encouraged the use of the tool and, in many cases, its clinicians may be using it outside of the organisation's knowledge. This panel discussion seeks to explore the broader benefits of using a safe, secure and compliant clinical communications platform, including integrating with other clinical systems; recording discussions as part of the patient record; and improving efficiencies and working practices for busy clinicians at a time when the elective care backlog is particularly challenging. This session is delivered in partnership with Feedback Medical Ltd Speakers Darryn Hale, Senior Associate - DAC Beachcroft Dr Tom Oakley, CEO - Feedback Medical Ltd
I agree, we are at a critical point here, just need a few more trusts on board and a snowball effect could soon follow. I understand the frustration. The Pennine Trust must go to contract soon surely, it is a bit concerning that more haven't yet got onboard. Will give it a few more months during this critical period.
Crazy indeed Elartu, also heard on radio 2 this morning that Boris was making £1billion available to takle the backlog , If Tom's figures from the Pennine trial are correct then bleepa would be an an essential buy for the NHS; and relatively cheap. Surely this is a salesman's dream.
I agree tb , the US big tech has got too big and dominant, I think the government now recognise this as they are closing down our high street, allowing British tech to gain a foothold is definitely needed, government around the world now trying to claw back tax off the big players, times are changing and this could be our time.